Skip to main content
Signal8

Zura Bio Ltd (ZURA)

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Zura Bio Limited logo

Zura Bio Limited

NASDAQ:ZURAHealthcare
AH-0.48%$1.03
Close$1.03-4.17%
Mkt Cap$99.7M
EV-
Float68.65M
O/S96.33M
VOL3.52M sh
$ Vol$3.58M
RVOL0.47×
Inst Own71.9%
Net Cash/Sh-
EarningsMar 31 · in 4mo
Dilution
Zura Bio Limited logoNASDAQ:ZURAAH$1.03-0.48%
Short interest (FINRA)
Not computed: short interest % needs a single float figure, and the float on record is a bound or estimate.
Oct 30 (18d)
8.5M
Oct 30 (18d)prev 7.0M▲ 20.7%
1.79
Oct 30 (18d)prev 1.47▲ 21.8%
Borrow (IBKR)

The cost to borrow ZURA shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
24.9%
Nov 16 (1d)prev 8.4%▲ 16.5 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

24
Oct 23 (25d)prev 2.6K▼ 99.1%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver19 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20268.5M sh
Oct 15, 20267.0M sh
Sep 30, 20269.4M sh
Sep 15, 20269.3M sh
Aug 31, 202611.1M sh
Latest fails to deliver
DateShares failed
Oct 23, 202624 sh
Oct 13, 20262.6K sh
Sep 21, 20269.2K sh
Sep 10, 202618.3K sh
Aug 5, 20264 sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202624.9%
Nov 13, 20268.4%
Nov 12, 202618.3%
Nov 11, 202623.5%
Nov 10, 202617.2%
90-session median 54.4%mean 51.6%range 8.4–83.8%

130 calendar days requested; 91 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for ZURA: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 8,471,655 ZURA shares were sold short (1.79 days to cover).